EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

James E Wagner Cultivation Corp (JWCAF) fair value: what the stock is really worth

As of Sep 18, 2026: fair value of James E Wagner Cultivation Corp $0.00, price $0.00, upside +0.0%, quality 17 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · Home Canada · ISIN CA47031P1080

JE James E Wagner Cultivation Corp logo Thin data Sep 24, 2026

James E Wagner Cultivation Corp

JWCAF · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.0001 · Fairly valued (+0%)
!Quality 17/100
!Mixed Growth (revenue YoY +3598.6 %/yr)
✓Low debt
!Trails peers (1/6)
!Narrow moat 3/100
!Evidence only low, so the estimate is less certain
Watch James E Wagner Cultivation Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.00 $0.0001 Fair Value $0.0001 Jun 2018 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $0.0001 – $1.00 · the $0.0001 price screens below the $0.0001 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow James E Wagner Cultivation in your weekly email

Every Wednesday you see whether James E Wagner Cultivation is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E.

Show more

James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.

Stock analysis

James E Wagner Cultivation Corp (JWCAF) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 84/100, which puts the evidence level at low.

Quality & growth

The Quality Score stands at 17/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

James E Wagner Cultivation Corp reported revenue of C$2.1M in FY2019 versus C$0 in FY2016. Reported net income was −C$7.0M in FY2019.

Key figures

Market cap $10.9K · EPS (TTM) $−0.3100 · Return on equity −50.3% · Return on assets (EBIT) −44.9% · Operating margin −271% · Revenue (TTM) C$2.5M · Revenue growth (YoY) −56.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and at its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at 0%, JWCAF screens cheaper than that median.

Fair Value models

Bear $0.0001 Fair Value $0.0001 Bull $0.0001
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.0001 $0.0001 $0.0001 54
All 1 models by family
Asset-Based
NCAV (Graham) $0.0001 $0.0001 $0.0001 54

Open the full fair value analysis →

Notify me when JWCAF reaches fair value

Put JWCAF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 17/100

Of which business quality 22 · Market factors (momentum, volatility) 56

Profitability 0
Margins and returns on capital today
Quality Growth 74
Are margins and returns improving?
Cashflow 18
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 2 usable fiscal years, at least 4 required
not computed

Watch JWCAF, get fair value alerts →

Compare James E Wagner Cultivation Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 629 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 22 · Bottom 25%
Fair Value upside +0% · Above median
Profitability
Return on assets −14% · Bottom 25%
Growth and dividend
Revenue growth −56% · Bottom 25%
Balance sheet
Debt / equity 0.27× · Above median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)33 · sector 15
FUTURE (revenue growth)0 · sector 20
PAST (return on equity)0 · sector 27
HEALTH (low debt)87 · sector 96
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €133.95 €108.70 −19%
Takeda Pharmaceutical Company TAK $18.81 $11.29 −40%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥45.58 ¥50.14 +10%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,865 ₹1,979 +6%
Galderma Group GALD CHF 163.80 CHF 109.88 −33%
Haleon plc HLN $9.25 $8.50 −8%
Teva Pharmaceutical Industries Limited TEVA $39.01 $20.75 −47%
Sandoz Group SDZ CHF 70.76 CHF 40.16 −43%
Zoetis Inc ZTS $71.61 $108.48 +51%
Hansoh Pharmaceutical Group 3692 HK$35.34 HK$38.87 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "James E Wagner Cultivation Corp Fair Value". https://www.fairvalue-calculator.com/stock/JWCAF

Frequently asked questions

Is James E Wagner Cultivation Corp (JWCAF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0001 versus the last price from Sep 18, 2026 of $0.0001, about +0% upside (fairly valued).
What is the fair value of JWCAF?
Our model-based fair value for James E Wagner Cultivation Corp is $0.0001 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $0.0001.
What is the quality score of JWCAF?
James E Wagner Cultivation Corp has a Quality Score of 17/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for James E Wagner Cultivation Corp (JWCAF)?
Our model-based price target is the fair value of $0.0001 (as of Sep 24, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the James E Wagner Cultivation Corp stock forecast for 2026?
Our models put fair value at $0.0001, about +0% upside versus the last price from Sep 18, 2026 of $0.0001 (fairly valued). The calculation is refreshed regularly with new filings.
What is the revenue of James E Wagner Cultivation Corp (JWCAF)?
James E Wagner Cultivation Corp reported trailing-twelve-month revenue of about C$2.5M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of James E Wagner Cultivation Corp (JWCAF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For James E Wagner Cultivation Corp it is $0.0001 per share (as of Sep 24, 2026), against a price of $0.0001. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is James E Wagner Cultivation Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, JWCAF trades below its calculated fair value: price $0.0001, fair value $0.0001, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of JWCAF?
No. The price is what the market pays today ($0.0001); the fair value is what the company's own numbers justify ($0.0001). For James E Wagner Cultivation Corp the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is James E Wagner Cultivation Corp worth?
The market values James E Wagner Cultivation Corp at about $10.9K (market capitalisation, as of Sep 24, 2026). Per share that is $0.0001; our models calculate a fair value of $0.0001 per share.
How solid is the balance sheet of James E Wagner Cultivation Corp (JWCAF)?
Balance-sheet figures for James E Wagner Cultivation Corp (as of Sep 24, 2026): return on equity −50.3%, debt of 0.27 per unit of equity. They feed the Quality Score of 17/100, which measures business quality independently of the share price.
How far is JWCAF from its 52-week high?
James E Wagner Cultivation Corp trades at $0.0001, at its 52-week high of $0.0001 and at the low of $0.0001 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0001 is for.
Which stocks are comparable to James E Wagner Cultivation Corp?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is James E Wagner Cultivation Corp stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0001, calculated fair value $0.0001 (+0%), Quality Score 17/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of JWCAF calculated?
We run James E Wagner Cultivation Corp through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0001, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. James E Wagner Cultivation Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of James E Wagner Cultivation Corp (JWCAF)?
The latest price we hold is from Sep 18, 2026 and stands at $0.0001. Our model-based fair value is $0.0001, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with James E Wagner Cultivation Corp right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of James E Wagner Cultivation Corp

How large is the market capitalisation of James E Wagner Cultivation Corp (JWCAF)?
The market capitalisation of James E Wagner Cultivation Corp is $10.9K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of James E Wagner Cultivation Corp (JWCAF)?
Earnings per share at James E Wagner Cultivation Corp are $−0.3100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of James E Wagner Cultivation Corp (JWCAF)?
The return on equity (ROE) of James E Wagner Cultivation Corp is −50.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of James E Wagner Cultivation Corp (JWCAF)?
On an EBIT basis the return on assets of James E Wagner Cultivation Corp is −44.9% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of James E Wagner Cultivation Corp (JWCAF)?
The operating margin of James E Wagner Cultivation Corp is −271% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at James E Wagner Cultivation Corp (JWCAF)?
Revenue at James E Wagner Cultivation Corp is growing −56.4% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
Free · no account needed

Watch James E Wagner Cultivation Corp in the live analysis

One click puts James E Wagner Cultivation Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.